Acetaldehyde Dehydrogenase Modulation for Alcohol Toxicity Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Individuals with the ALDH2*2 mutation are highly sensitive to alcohol consumption due to increased acetaldehyde accumulation, leading to adverse symptoms and higher risks of diseases like esophageal squamous cell cancer, as existing methods fail to effectively modulate acetaldehyde levels.
Innovation Solution
Administering compounds that modulate the expression or activity of acetaldehyde dehydrogenase enzymes, such as phase 2 inducers like sulforaphane, to increase enzyme activity and reduce acetaldehyde levels in the body.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If compounds are administered to increase ALDH enzyme activity, then acetaldehyde metabolism rate increases, but the complexity of the treatment composition increases
Solution Approach 1:
The patent employs dietary supplements containing natural compounds (broccoli extract, sulforaphane, vitamins) that are inexpensive, readily available, and act as temporary enhancers of ALDH activity. These compounds do not require complex formulation or long-term storage,而是提供简便的短期干预方案
Solution Approach 2:
The invention leverages the body's own ALDH enzyme system to metabolize acetaldehyde. By administering compounds that naturally induce or enhance ALDH activity (such as phase 2 inducers), the body's inherent metabolic pathways are activated without requiring external complex treatment systems
2Object-affected harmful factors
If acetaldehyde dehydrogenase activity is increased to reduce acetaldehyde levels, then alcohol toxicity is reduced, but the difficulty of detecting and measuring enzyme activity increases
Solution Approach 1:
The patent uses phase 2 inducers (such as sulforaphane from broccoli) as intermediary compounds that indirectly enhance ALDH activity. These intermediaries activate cellular pathways (Nrf2 pathway) that lead to increased ALDH expression and activity, providing a measurable effect on acetaldehyde metabolism without requiring direct measurement of complex enzyme kinetics
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Effectively reduces peak blood levels of acetaldehyde and increases its metabolism, alleviating toxicity and reducing the risk of associated health issues, including esophageal cancer, in individuals with the ALDH2*2 mutation.
Implementation Method 1
Acetaldehyde is metabolized to non-toxic acetate by acetaldehyde dehydrogenases, predominantly the cytosolic ALDH1 and mitochondrial ALDH2
Implementation Method 2
administering an effective amount of a composition comprising a compound that modulates the expression of acetaldehyde dehydrogenase (ALDH) in at least one cell of a subject
Data Source
Figure 1A~1B
Figure 2
Figure 3
AI summary
The present invention comprises methods and compositions for reducing ethanol toxicity due to accumulation of acetaldehyde in a cell. A method comprises administering to a cell a composition comprising a compound that increases the expression, the amount of, and/or the activity of at least one member of the aldehyde dehydrogenase superfamily.